Chronic Treatment with Multi-Kinase Inhibitors Causes Differential Toxicities on Skeletal and Cardiac Muscles

Despite recent progress, chemotherapy remains the preferred treatment for cancer. We have shown a link between anticancer drugs and the development of cachexia, i.e., body wasting accompanied by muscle loss. The multi-kinase inhibitors (MKIs) regorafenib and sorafenib, used as second-line treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Huot, Joshua R., Essex, Alyson L., Gutierrez, Maya, Barreto, Rafael, Wang, Meijing, Waning, David L., Plotkin, Lilian I., Bonetto, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520777/
https://www.ncbi.nlm.nih.gov/pubmed/31018508
http://dx.doi.org/10.3390/cancers11040571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520777/
https://www.ncbi.nlm.nih.gov/pubmed/31018508
http://dx.doi.org/10.3390/cancers11040571

Ejemplares similares